AADRAdvisorShares Dorsey Wright
The schedule
- Thu29Oct
(Driven by BBVA) Market evaluation of Q3 Net Interest Margin (NIM) trajectory against the backdrop of global rate cuts and Mexican peso volatility.
- Sun6Dec
(Driven by DBVT) The 60-day FDA decision window to officially accept DBVT's Viaskin Peanut application for review and assign a late 2027 PDUFA date. Base price is $15.00.
- Thu10Dec
(Driven by TEVA) Potential executive action or tariff review by the Trump Administration targeting foreign drug manufacturing and generic supply chains, anchored at $39.00.
- Tue9Feb
(Driven by BBVA) Release of fiscal year-end results and the crucial forward-looking 2027 Net Interest Income (NII) guidance.
- Mon15Mar
(Driven by BBVA) Expected government resolution regarding the extension or modification of extraordinary banking sector levies in Spain.
- Thu29Apr
(Driven by BBVA) First-quarter update focusing on capital distribution sustainability and early-year loan origination volumes.
- Tue15Jun
(Driven by TEVA) Mid-year assessment of lingering legal settlement payouts and debt refinancing efforts, starting at $45.50.
- Thu5Aug
(Driven by BBVA) Mid-year financial results evaluating the concrete impact of US trade policies on the Mexican economy and cross-border commercial flows.
Past
- Tue30Jun
Actual outcome: Bear · $82.95 at outcome
Embraer's Q2 2026 results and updated guidance failed to deliver the sustained double-digit revenue growth and sharp earnings leverage investors were anticipating. Margin pressures and a softer full-year outlook weighed heavily on sentiment, causing the stock to breach the bear floor.
Embraer's Q2 2026 results and updated guidance failed to deliver the sustained double-digit revenue growth and sharp earnings leverage investors were anticipating. Margin pressures and a softer full-year outlook weighed heavily on sentiment, causing the stock to breach the bear floor.
- Fri15May
Actual outcome: Bear · $83.57 at outcome
MUFG's FY25 results and FY26 guidance highlighted emerging margin compression and a cautious credit outlook, raising concerns over its rate-sensitive net interest margins. The disclosure of rising non-performing loans and softer loan growth projections weighed on investor sentiment, driving the stock below the bear floor.
MUFG's FY25 results and FY26 guidance highlighted emerging margin compression and a cautious credit outlook, raising concerns over its rate-sensitive net interest margins. The disclosure of rising non-performing loans and softer loan growth projections weighed on investor sentiment, driving the stock below the bear floor.
- Thu14May
Actual outcome: Bull · $86.44 at outcome
Buenaventura (BVN) delivered a strong Q1 2026 earnings report, highlighted by better-than-expected production volumes and solid forward guidance. This robust operational performance initially drove the ETF to reach its bull target, even though it experienced a slight retracement by the outcome date.
Buenaventura (BVN) delivered a strong Q1 2026 earnings report, highlighted by better-than-expected production volumes and solid forward guidance. This robust operational performance initially drove the ETF to reach its bull target, even though it experienced a slight retracement by the outcome date.